| __timestamp | Biogen Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 1893422000 | 152500000 |
| Thursday, January 1, 2015 | 2012800000 | 187800000 |
| Friday, January 1, 2016 | 1973300000 | 184000000 |
| Sunday, January 1, 2017 | 2253600000 | 167700000 |
| Monday, January 1, 2018 | 2597200000 | 218600000 |
| Tuesday, January 1, 2019 | 2280600000 | 187400000 |
| Wednesday, January 1, 2020 | 3990900000 | 177700000 |
| Friday, January 1, 2021 | 2501200000 | 122000000 |
| Saturday, January 1, 2022 | 2231100000 | 123100000 |
| Sunday, January 1, 2023 | 2702600000 | 122500000 |
| Monday, January 1, 2024 | 2041800000 |
Cracking the code
In the competitive landscape of the pharmaceutical industry, innovation is key. Biogen Inc. and Perrigo Company plc, two giants in the field, have shown contrasting approaches to research and development (R&D) spending over the past decade. From 2014 to 2023, Biogen's R&D expenses have surged by approximately 43%, peaking in 2020 with a remarkable 4 billion dollars. This reflects Biogen's commitment to pioneering new treatments and maintaining its competitive edge. In contrast, Perrigo's R&D spending has remained relatively stable, with a slight decline of around 20% over the same period. This strategic choice may indicate a focus on optimizing existing products rather than venturing into new territories. As the industry evolves, these spending patterns highlight the diverse strategies companies employ to drive growth and innovation.
Research and Development Investment: Eli Lilly and Company vs Perrigo Company plc
Merck & Co., Inc. vs Biogen Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Perrigo Company plc
Biogen Inc. or Insmed Incorporated: Who Invests More in Innovation?
Research and Development Investment: Biogen Inc. vs United Therapeutics Corporation
Research and Development Expenses Breakdown: Biogen Inc. vs Madrigal Pharmaceuticals, Inc.
Gross Profit Comparison: Biogen Inc. and Perrigo Company plc Trends
Research and Development Investment: Biogen Inc. vs Iovance Biotherapeutics, Inc.
Analyzing R&D Budgets: Biogen Inc. vs Wave Life Sciences Ltd.
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Perrigo Company plc
R&D Spending Showdown: Perrigo Company plc vs MannKind Corporation
Perrigo Company plc vs Wave Life Sciences Ltd.: Strategic Focus on R&D Spending